Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Dolphin Intertrade Corporation to request your refund or repair — edit it as you like.
Subject: Recall D-1250-2014 — Dolphin Intertrade Corporation Dolphin Intertrade Corporation recalls XIYOUJI QINGZHI CAPSULE, 300m Hello, I own a Dolphin Intertrade Corporation recalls XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box that is covered by recall D-1250-2014 from Dolphin Intertrade Corporation. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
